Ascentage Pharma Group International American Depository Shares (AAPG)
Nasdaq: AAPG · Pharmaceutical Preparations · Suzhou , Jiangsu, CN · filing with the SEC since 2024
Who runs Ascentage Pharma Group International American Depository Shares
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Yang Dajun
Chairman and CEO. First filing Mar 2026, latest May 22, 2026, 0 filings in all.
Officers reporting now
6
of 14 people with a filing in the last fifteen months
Directors reporting now
8
14 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Miyara Faical | Chief Business Officer | Jun 2026 | Jun 29, 2026 | none |
| Yang Dajun | Chairman and CEO | Mar 2026 | May 22, 2026 | none |
| Zhai Yifan | Chief Medical Officer | Mar 2026 | May 22, 2026 | none |
| Misra Veet | Chief Financial Officer | Apr 2026 | Apr 21, 2026 | none |
| Cao Jin | Chief Accounting Officer | Apr 2026 | Apr 20, 2026 | none |
| Knapp Thomas J | SVP/General Counsel | Mar 2026 | Mar 23, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bozilenko Marina | director | Mar 2026 | Mar 23, 2026 | none |
| Lippman Marc E | director | Mar 2026 | Mar 23, 2026 | none |
| Lu Simon Dazhong | director | Mar 2026 | Mar 23, 2026 | none |
| Sidransky David | director | Mar 2026 | Mar 23, 2026 | none |
| Wang Shaomeng | director | Mar 2026 | Mar 23, 2026 | none |
| Wei Ren | director | Mar 2026 | Mar 23, 2026 | none |
| Ye Changqing | director | Mar 2026 | Mar 23, 2026 | none |
| Yu Debra | director | Mar 2026 | Mar 23, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.